- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Health
Investors bet on fusion payoff within a decade
Stellarators are emerging as one of the most backable fusion technologies, and investors say the first pilot reactors could be working by the end of the decade.
Dec 15, 2023McBride joins GV as a general partner
Alphabet’s early-stage investment unit has hired Michael McBride to seek out AI and open-source software startups.
Dec 14, 2023How dominant CVCs stalled the Thai tech ecosystem
After a promising start the Thai startup ecosystem has slowed. Some say too much corporate money may have been part of the problem.
Dec 14, 2023Is Bitcoin bouncing back? November sees a rise in crypto deals
There was a promising (or surprising) rise in corporate-backed funding rounds for cryptocurrency startups in November. Despite many heralding the demise of crypto, it looks like it isn't dead yet.
Dec 12, 2023US consultancy forms healthcare investment unit
Pioneer Management Consulting has launched a venture capital firm to invest in startups developing treatments for rare brain tumours.
Dec 7, 2023Intuitive Ventures closes $150m second fund
The Intuitive Ventures Fund II will invest in startups transforming treatment in minimally invasive care.
Dec 5, 2023American Heart Association hires Suennen at new venture unit
The American Heart Association has launched AHA Ventures to invest in health tech and social impact.
Dec 4, 2023Let's talk about sex: How CVCs are missing out on a huge…
Corporate investors rarely back sex startups but as attitudes change and the trend for sexual health and education picks up, are they missing out?
Dec 4, 2023Austrian emergency services group launches venture studio
ÖAMTC will use the venture studio to explore new business areas related to the demographic change of its members.
Dec 1, 2023Dos Santos joins Takeda Digital Ventures
CVC veteran Ricardo dos Santos has left ResMed and joined Takeda’s digital health investment arm as partner and head of its Venture Studio.
Nov 29, 2023M Ventures looks to AI to drive medicine and materials forward
Merck Group’s CVC managing directors Owen Lozman and Hakan Goker speak about the transformational power of machine learning in pharma and materials science.
Nov 24, 2023CVC Unplugged: How Merck Group's CVC is closing in on hard-to-treat diseases
M Ventures' managing directors Hakan Goker and Owen Lozman explore the future of biotech and frontier technology.
Nov 21, 2023Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
